a9-dpc
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 9, 2023 (NCT05887466)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetSupplementation
supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06477744 | N/A | Sep 14, 2023 | S.Biomedics Co., Ltd., Yonsei University |
| NCT05887466 | Phase 1/Phase 2 (Phase 2) | May 9, 2023 | S.Biomedics Co., Ltd., Yonsei University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| S.Biomedics Co., Ltd. | For profit | 2 | 2 | 2 | 2023 |
| Yonsei University | Academic/Hospital | 2 | 0 | 2 | 2023 |
2 organizations
Page 1 / 1